|
Kandace J. Landreneau, PhD, RN, CCTC
|
Kandace J. Landreneau, PhD, RN, CCTC, is
Associate Professor of Nursing, University of Texas,
Tyler, TX. She is a member of ANNA’s Acadiana
Chapter. For more information on this article, contact
the author at kandacel@msn.com.
|
|
Peggy Ward-Smith, PhD, RN
|
Peggy Ward-Smith, PhD, RN, is Associate
Professor of Nursing, University of Missouri, Kansas
City, MO.
|
Purpose: The aim of this study was to explore what patients on hemodialysis perceive concerning choice
among three types of renal replacement therapies: transplantation, hemodialysis, and peritoneal dialysis.
Method: A qualitative phenomenological research design was employed in this exploratory, descriptive
study. A convenience sample was recruited from two urban dialysis units in the southern part of the United
States. The analysis was performed using Colaizzi’s (1978) phenomenological technique.
Results: Two themes emerged from analysis: knowledge and choice. Participants perceived choice in their
renal replacement therapies. The predominant theme reflected that most participants had knowledge about
at least two of the three types of renal replacement therapies.
Conclusion: The areas of choice among renal replacement therapies, education about all renal replacement
therapies, and other dynamics that impact choice, need to be studied. Inquiry needs to remain treatment
specific and include all renal replacement treatments available to the patient. Future studies should
continue to investigate perceptions of choice, and no assumption should be made about whether patients
undergoing hemodialysis are receiving information or education on all the options for renal replacement
therapy. Additional research within this area will validate needs and concerns of these patients.
|
CE
RELATED INFORMATION |
|
This
offering for 1.5 contact
hours is being provided by
the
American
Nephrology Nurses Association
(ANNA), which
is accredited as a provider
and approver of continuing
education in nursing by
the American Nurses
Credentialing Center-Commission
on Accreditation (ANCCCOA).
This educational activity
is approved by most states
and specialty organizations
that recognize the ANCC-COA
accreditation process. ANNA
is an approved provider of
continuing education in nursing
by the California Board of
Registered Nursing, BRN Provider
No. 00910; and the Kansas
State Board of Nursing, Provider
No. LT0148-0738. This offering
is accepted for RN and LPN
relicensure in Kansas
|
|
Goal:
Explore what patients on hemodialysis perceive concerning choice among three
types of renal replacement therapies.
Objectives:
1. State the three types of renal replacement therapies.
2. Discuss two themes which emerged from the study.
3. Formulate a statement about how a patient on hemodialysis could perceive
their choice among renal replacement therapies.
|
AUTHOR DISCLOSURE
STATEMENT |
Kandace J. Landreneau
has no conflicts of interest to disclose.
Peggy Ward-Smith
has no conflicts of interest to disclose.
|
ANNA and HDCN CE POLICY STATEMENTS |
The CE policy and disclosure statements of the American Nephrology
Nurses' Association are given in detail on the Symposium
Home Page. The CE policy statements of HDCN are listed on
this page. |